Home/Filings/4/0001209191-09-019005
4//SEC Filing

Varanasi Ramani 4

Accession 0001209191-09-019005

CIK 0001390478other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 5:38 PM ET

Size

8.7 KB

Accession

0001209191-09-019005

Insider Transaction Report

Form 4
Period: 2009-03-27
Varanasi Ramani
VP, Business Development
Transactions
  • Award

    Stock Option

    2009-03-27+14,76014,760 total
    Exercise: $4.98Exp: 2019-03-27Common Stock (14,760 underlying)
  • Award

    Stock Option

    2009-03-27+85,240100,000 total
    Exercise: $4.98Exp: 2019-03-27Common Stock (85,240 underlying)
Footnotes (4)
  • [F1]Granted pursuant to the RXi Pharmaceuticals Corporation 2007 Incentive Plan.
  • [F2]Per share.
  • [F3]The options will vest in equal installments of 4,920 shares on each of December 25, 2010, December 25, 2011 and December 25, 2011.
  • [F4]The options will vest in the following increments on the following dates: 6,250 shares on June 25, 2009, 6,250 shares on September 25, 2009, 6,250 shares on December 25, 2009, 6,250 shares on March 25, 2010, 6,250 shares on June 25, 2010, 6,250 shares on September 25, 2010, 1,330 shares on December 25, 2010, 6,250 shares on shares on March 25, 2011, 6,250 shares on June 25, 2011, 6,250 shares on September 25, 2011, 1,330 shares on December 25, 2011, 6,250 shares on March 25, 2012, 6,250 shares on June 25, 2012, 6,250 shares on September 25, 2012, 1,330 shares on December 25, 2012 and 6, 250 shares on March 25, 2013.

Issuer

RXI PHARMACEUTICALS CORP

CIK 0001390478

Entity typeother

Related Parties

1
  • filerCIK 0001460224

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:38 PM ET
Size
8.7 KB